Cor triatriatum is a rare congenital heart defect characterized by the presence of a fibromuscular membrane that divides the atrium into two chambers. The prevalence of this condition is quite low, making it a relatively uncommon finding. Although exact statistics are limited, it is estimated to occur in approximately 0.1% to 0.4% of all congenital heart defects.
Cor triatriatum can affect individuals of all ages, from infants to adults, and can present with a wide range of symptoms depending on the severity of the obstruction caused by the membrane. Common symptoms include shortness of breath, fatigue, palpitations, and recurrent respiratory infections.
Diagnosis of cor triatriatum typically involves a combination of imaging techniques such as echocardiography, cardiac MRI, and cardiac catheterization. Treatment options vary depending on the severity of the condition and the presence of associated cardiac abnormalities. Surgical intervention, such as membrane resection or balloon dilation, is often required to alleviate the obstruction and improve cardiac function.
While cor triatriatum is a relatively rare condition, early diagnosis and appropriate management are crucial for optimizing patient outcomes. Regular follow-up with a cardiologist is recommended for individuals with this condition to monitor their cardiac health and address any potential complications.